4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-062400
SVP, Chief Accounting Officer sold 2,031 shares at $43.96 ($89,283)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huizenga Theodore Alan SVP, Chief Accounting Officer | 2022-12-21 | Sale | −2,031 | $43.96 | $89,283 | 16,197 | D: show line 1 in the form |
| Open-market sales · 2,031 sh · avg $43.96 · $89,283 | |||||||
Loading xslF345X03/doc4.xml…